School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia.
Front Endocrinol (Lausanne). 2023 Jul 26;14:1205219. doi: 10.3389/fendo.2023.1205219. eCollection 2023.
Diabetes is the fastest growing chronic disease globally, with prevalence increasing at a faster rate than heart disease and cancer. While the disease presents clinically as chronic hyperglycaemia, two distinct subtypes have been recognised. Type 1 diabetes (T1D) is characterised as an autoimmune disease in which the insulin-producing pancreatic β-cells are destroyed, and type 2 diabetes (T2D) arises due to metabolic insufficiency, in which inadequate amounts of insulin are produced, and/or the actions of insulin are diminished. It is now apparent that pro-inflammatory responses cause a loss of functional β-cell mass, and this is the common underlying mechanism of both T1D and T2D. Macrophages are the central immune cells in the pathogenesis of both diseases and play a major role in the initiation and perpetuation of the proinflammatory responses that compromise β-cell function. Furthermore, it is the crosstalk between macrophages and β-cells that orchestrates the inflammatory response and ensuing β-cell dysfunction/destruction. Conversely, this crosstalk can induce immune tolerance and preservation of β-cell mass and function. Thus, specifically targeting the intercellular communication between macrophages and β-cells offers a unique strategy to prevent/halt the islet inflammatory events underpinning T1D and T2D. Due to their potent ability to regulate mammalian immune responses, parasitic worms (helminths), and their excretory/secretory products, have been examined for their potential as therapeutic agents for both T1D and T2D. This research has yielded positive results in disease prevention, both clinically and in animal models. However, the focus of research has been on the modulation of immune cells and their effectors. This approach has ignored the direct effects of helminths and their products on β-cells, and the modulation of signal exchange between macrophages and β-cells. This review explores how the alterations to macrophages induced by helminths, and their products, influence the crosstalk with β-cells to promote their function and survival. In addition, the evidence that parasite-derived products interact directly with endocrine cells to influence their communication with macrophages to prevent β-cell death and enhance function is discussed. This new paradigm of two-way metabolic conversations between endocrine cells and macrophages opens new avenues for the treatment of immune-mediated metabolic disease.
糖尿病是全球增长最快的慢性病,其患病率的增长速度超过心脏病和癌症。虽然这种疾病在临床上表现为慢性高血糖,但已经认识到有两种不同的亚型。1 型糖尿病 (T1D) 是一种自身免疫性疾病,其中产生胰岛素的胰腺β细胞被破坏,而 2 型糖尿病 (T2D) 则由于代谢不足而发生,即产生的胰岛素不足,和/或胰岛素的作用减弱。现在很明显,促炎反应导致功能性β细胞质量的丧失,这是 T1D 和 T2D 的共同潜在机制。巨噬细胞是这两种疾病发病机制中的核心免疫细胞,在启动和维持损害β细胞功能的促炎反应中发挥主要作用。此外,巨噬细胞和β细胞之间的串扰协调了炎症反应和随后的β细胞功能障碍/破坏。相反,这种串扰可以诱导免疫耐受并维持β细胞的质量和功能。因此,专门针对巨噬细胞和β细胞之间的细胞间通讯提供了一种独特的策略,可以防止/阻止 T1D 和 T2D 中潜在的胰岛炎症事件。由于寄生虫(蠕虫)及其排泄/分泌产物具有调节哺乳动物免疫反应的强大能力,因此它们已被作为 T1D 和 T2D 的治疗剂进行了研究。这项研究在临床和动物模型中都取得了预防疾病的积极成果。然而,研究的重点一直是免疫细胞及其效应物的调节。这种方法忽略了蠕虫及其产物对β细胞的直接影响,以及巨噬细胞和β细胞之间信号交换的调节。这篇综述探讨了蠕虫及其产物诱导的巨噬细胞变化如何影响与β细胞的串扰,以促进其功能和存活。此外,还讨论了寄生虫衍生产物与内分泌细胞直接相互作用以影响它们与巨噬细胞的通讯以防止β细胞死亡并增强功能的证据。这种内分泌细胞和巨噬细胞之间双向代谢对话的新模式为治疗免疫介导的代谢疾病开辟了新途径。